Fox Corporate Finance

MARCH 20, 2024

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 01/2024”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 01/2024 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Harvard Corporate Governance

MARCH 20, 2023

In 2022, the total number of securities class action complaints filed remained below the more elevated levels we saw during 2017-2020, but life sciences companies were nonetheless still popular targets among these filings. [1] Filings against life sciences companies in 2022 represented a 27.1% decrease from the previous year, and a 51.1%

130

130

Viking Mergers

NOVEMBER 21, 2022

The reality is, conducting a thorough and accurate business valuation is both an art and a science. The business advisors at Viking Mergers & Acquisitions are masters of both the art and science of valuing businesses. The Science of Business Valuation. Business Valuations: A Brief Guide for Beginners.

Business Valuation 130

Business Valuation Start-ups Data Analysis Appraisal 130

Fox Corporate Finance

JANUARY 25, 2024

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 12/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 12/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Benzinga

APRIL 10, 2024

Alpine Immune Sciences Inc (NASDAQ: ALPN ) is reportedly considering strategic options, including a potential sale, following interest from potential buyers. The Seattle-based firm is working closely with advisors and evaluating various possibilities, and at least one major pharmaceutical player has expressed interest in an acquisition.

59

59

Law 360 M&A

JANUARY 31, 2024

Orrick Herrington & Sutcliffe LLP said Wednesday that it had hired its 34th life sciences partner in three years, welcoming the former head of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP's licensing, strategic partnering and commercial transactions group.

52

52

Fox Corporate Finance

DECEMBER 14, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 11/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 11/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Mckinsey and Company

AUGUST 3, 2022

For life science companies to meet their digital ambitions, they must strengthen their technology skills. In a challenging market, emphasizing value propositions can attract first-rate talent.

Technology 105

Technology Marketability 105

Mckinsey and Company

JANUARY 31, 2023

Life sciences companies are making progress in adopting and deploying digital and analytics. But they can go further and faster by heeding some lessons from the past few years.

93

93

Fox Corporate Finance

NOVEMBER 27, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Avanade

MARCH 5, 2023

The potential in health and life sciences for ChatGPT and open AI, more generally called generative AI, is enormous, but like any other technology, we need to identify how to leverage it and how to get started.

Technology 105

Technology 105

Fox Corporate Finance

JUNE 29, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 05/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

OCTOBER 11, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 09/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 09/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

MAY 11, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

SEPTEMBER 20, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 08/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 08/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Mckinsey and Company

NOVEMBER 30, 2022

Persuaded by her parents to study science and engineering, Jayshree Seth retained her humanities mindset while becoming the first chief science advocate at the 3M company.

89

89

Mckinsey and Company

DECEMBER 14, 2022

As the life sciences industry is tested by an uncertain economic environment, companies can focus not only on resilience but on positioning themselves to accelerate when coming out of the downturn.

75

75

Fox Corporate Finance

APRIL 20, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 03/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Benchmark Report

FEBRUARY 9, 2024

Benchmark International Successfully Facilitated The Transaction Between Data Science Automation (DSA) And Blackford Capital

Private Equity Firm 64

Private Equity Firm Technology Equity 64

Fox Corporate Finance

MARCH 30, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 02/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Business Wire M&A

FEBRUARY 14, 2023

CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the strategic investment and continued growth of Spectrum Science (“Spectrum”) by private equity sponsor Knox Lane. Based in Washington D.C.,

Equity 75

Equity Marketability 75

Mckinsey and Company

SEPTEMBER 14, 2022

Life sciences companies pursuing a step change in performance have obtained mixed results. Adhering to five principles can greatly improve the odds of a large transformation program succeeding.

86

86

Fox Corporate Finance

MARCH 10, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

AUGUST 9, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 07/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 07/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

JULY 19, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 06/2023”. Read more The post FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 06/2023 published appeared first on FCF Fox Corporate Finance GmbH.

Corporate Finance 52

Corporate Finance Finance 52

Avanade

DECEMBER 18, 2023

Erik Barnett outlines five areas within healthcare and life sciences where the U.S. executive order and federal support for responsible AI principles could impact deployment of generative AI in the U.S.

52

52

Fox Corporate Finance

FEBRUARY 1, 2023

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Mckinsey and Company

SEPTEMBER 22, 2023

As healthcare gets ever more personalized, Genentech is expanding innovation from the lab into marketing, in service of “science for good.” The biotech pioneer’s chief marketing officer tells how.

Marketability 63

Marketability 63

Fox Corporate Finance

DECEMBER 20, 2022

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

NOVEMBER 30, 2022

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 10/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Law 360 M&A

DECEMBER 15, 2023

Public offerings for life sciences companies have come to a nearly complete halt over the past few years, but healthcare insiders say we may see more companies in the space rushing to go public in 2024, though only a select few will have the resources and backing to accomplish that.

52

52

Business Wire M&A

MAY 5, 2023

WERTHEIM, Germany--(BUSINESS WIRE)--DWK Life Sciences (“DWK”), a leading global manufacturer and supplier of laboratory glassware, plasticware, and primary packaging solutions, has completed the acquisition of Assem-Pak | Aluseal (“Assem-Pak”), a U.S. company based in Vineland, New Jersey.

98

98

Fox Corporate Finance

NOVEMBER 3, 2022

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 09/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52

Fox Corporate Finance

SEPTEMBER 12, 2022

The FCF Life Sciences team continuously analyses the current sentiments in the European life sciences venture capital funding sector. All life sciences subsectors (i.e. The post Overall negative Life Sciences Sentiments recorded in August 2022 appeared first on FCF Fox Corporate Finance GmbH.

Venture Capital Fund 52

Venture Capital Fund Corporate Finance Finance 52

Law 360 M&A

DECEMBER 18, 2023

Dental and spine-focused life sciences company ZimVie Inc., advised by Cravath Swaine & Moore LLP, said Monday that it has agreed to sell its spine business to private equity shop H.I.G. Capital, advised by McDermott Will & Emery LLP, for a total consideration of $375 million.

Equity 52

Equity 52

Fox Corporate Finance

OCTOBER 14, 2022

In 2022, the venture capital funding for life sciences in Europe continues to weaken, further widening the gap to 2021 (EUR 9.4bn vs. EUR 6.5bn). The post European VC life sciences funding continues to decline appeared first on FCF Fox Corporate Finance GmbH. The cumulative financing volume in August 2022 falls by more.

Venture Capital Fund 52

Venture Capital Fund Corporate Finance Finance 52

Fox Corporate Finance

SEPTEMBER 8, 2022

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 08/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences.

Corporate Finance 52

Corporate Finance Finance 52